Logo image
Vulvovaginal candidiasis and bacterial vaginosis
Journal article   Peer reviewed

Vulvovaginal candidiasis and bacterial vaginosis

Paul Nyirjesy
Infectious disease clinics of North America, v 22(4), pp 637-652
Dec 2008
PMID: 18954756

Abstract

Adult Anti-Bacterial Agents - therapeutic use Antifungal Agents - therapeutic use Candidiasis, Vulvovaginal - diagnosis Candidiasis, Vulvovaginal - drug therapy Candidiasis, Vulvovaginal - microbiology Candidiasis, Vulvovaginal - physiopathology Female Humans Vaginosis, Bacterial - diagnosis Vaginosis, Bacterial - drug therapy Vaginosis, Bacterial - microbiology Vaginosis, Bacterial - physiopathology
Vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV) are frequently encountered in clinical practice. Recent advances have furthered understanding of pathophysiology. Proper diagnosis, based on appropriate office and, in complicated cases, laboratory tests is the key to rational selection of therapy. For women who have routine uncomplicated episodes of VVC or BV, a variety of effective treatment options exists. Recurrent disease remains a challenge for these conditions but can often be managed successfully.

Metrics

24 Record Views
67 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Immunology
Infectious Diseases
Logo image